Menu
Recruiting NCT07746804

School-based Myopia Prevention Trial for Children With Insufficient Hyperopic Reserve

No phase Interventional Refractive Errors Hyperopia Myopia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Auricular Acupressure, Eye Health Education.
Who it may be relevant to
Registry conditions: Refractive Errors, Hyperopia, Myopia. Basic parameters: 6 years — 11 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Randomized Controlled Trial of School-based Auricular Acupressure for Myopia Prevention in Non-myopic Children With Insufficient Hyperopic Reserve

Overview

This is a prospective, school-based randomized controlled trial designed to evaluate auricular acupressure for myopia prevention in non-myopic primary school students with insufficient hyperopic reserve. Enrolled students in grades 1 to 4 will be randomly assigned to either an auricular acupressure intervention or usual daily activities without additional study-related myopia prevention intervention. Outcomes will include changes in axial length and cycloplegic spherical equivalent refraction, incident myopia, intervention adherence, and safety outcomes over 12 months.

Detailed description

This prospective, school-based randomized controlled trial will be conducted among non-myopic children with insufficient hyperopic reserve. Eligible participants are students in grades 1 to 4 from participating primary schools who meet the eligibility criteria for insufficient hyperopic reserve and whose parents or legal guardians provide written informed consent.

Insufficient hyperopic reserve is defined as cycloplegic spherical equivalent refraction in the worse eye greater than +0.75 D but lower than the age-specific reference value for hyperopic reserve.

Within each participating school, students will be stratified by grade and randomly assigned in a 1:1 ratio to the intervention group or the control group. The intervention group will receive auricular acupressure administered according to the study protocol in addition to standard school-based eye health education. The control group will receive standard school-based eye health education only and will not receive auricular acupressure or other additional study-related myopia prevention intervention.

Comprehensive ophthalmic examinations will be conducted at baseline and 12 months according to the study protocol. An interim follow-up visit will be conducted at 6 months, including visual acuity assessment, non-cycloplegic autorefraction, and axial length measurement. The primary outcome is the change in axial length from baseline to 12 months. Secondary outcomes include the change in cycloplegic spherical equivalent refraction, the incidence of myopia during follow-up, adherence to auricular acupressure, and safety outcomes and adverse events.

Interventions

  • Other Auricular Acupressure
    Auricular acupressure will be performed using adhesive patches containing vaccaria seeds applied to selected auricular acupoints, including liver, spleen, heart, eye, kidney, Mu 1, Mu 2, and Shenmen. The intervention will be delivered once weekly by trained medical personnel according to a standardized protocol. Each application will remain in place for 5 days, followed by a 2-day rest period, with the treated ear alternated weekly. Participants will be instructed to press the patches three time
  • Behavioral Eye Health Education
    Standard school-based eye health education will include general guidance on healthy visual behaviors, near-work habits, reading posture, lighting conditions, eye exercises, and regular eye examinations.

Primary outcome measures

  • Change in axial length [Time frame: Baseline to 12 months]
Secondary outcome measures (4)
  • Change in cycloplegic spherical equivalent refraction [Time frame: Baseline to 12 months]
  • Incidence of myopia during follow-up [Time frame: During the 12-month follow-up period]
  • Adherence to auricular acupressure [Time frame: During the 12-month follow-up period]
  • Safety Outcomes and Adverse Events [Time frame: During the 12-month follow-up period]

Eligibility criteria

Inclusion criteria

  • Students in grades 1 to 4 from participating primary schools.
  • Non-myopic children with insufficient hyperopic reserve, defined as cycloplegic spherical equivalent refraction in the worse eye greater than +0.75 D and below the following age-specific upper limits: +1.72 D at age 6 years; +1.48 D at age 7 years; +1.19 D at age 8 years; +1.11 D at age 9 years; +0.92 D at age 10 years; and +0.83 D at age 11 years.
  • Written informed consent provided by a parent or legal guardian, with willingness to participate in baseline and follow-up assessments during the study period.

Exclusion criteria

  • Strabismus, amblyopia, or other ocular abnormalities.
  • Systemic disease or other medical conditions that may affect study participation.
  • Has received any myopia prevention intervention in the past 3 months.
  • Known skin sensitivity, local ear skin lesions, or other conditions judged unsuitable for auricular acupressure.
  • Any other condition judged by the study doctors to make participation inappropriate.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

China · 1 center
  • Shanghai Eye Disease Prevention and Treatment Center — Shanghai

Identifiers

NCT: NCT07746804 · KY2026-001-RE-012

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗